Thymosin Beta-4 was studied extensively in racehorses before transitioning to human research contexts, and that veterinary track record helped establish its safety profile before clinical use
Decide whether to continue, adjust, or complete the protocol
3 The registry record is listed with unknown status and does not provide a set of posted results sufficient to establish a public safety or effectiveness conclusion
Before beginning any treatment, it's essential to consult with a licensed healthcare provider to ensure the best approach for your individual health needs.
Since there are no FDA-approved versions of these peptides, compounding pharmacies could be the only pathway through which people could access these medications in the future, said Dresser, who has represented a number of compounding pharmacies
Typically it is safe for all patients and has no risk of being toxic